JJIJ

Johnson & Johnson Innovation - JJDC Portfolio holdings

AUM $978M
This Quarter Return
+42.02%
1 Year Return
+101.76%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$509M
AUM Growth
+$509M
Cap. Flow
+$249M
Cap. Flow %
48.99%
Top 10 Hldgs %
99.65%
Holding
15
New
3
Increased
–
Reduced
–
Closed
–

Top Buys

1
FATE icon
Fate Therapeutics
FATE
$116M
2
LEGN icon
Legend Biotech
LEGN
$69.3M
3
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$64.1M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 99.83%
2 Technology 0.17%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.05B
$141M 27.67% 3,260,869 – –
FATE icon
2
Fate Therapeutics
FATE
$120M
$116M 22.77% +3,379,064 New +$116M
LEGN icon
3
Legend Biotech
LEGN
$6.41B
$69.3M 13.62% +1,629,173 New +$69.3M
FUSN
4
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$64.1M 12.6% +3,670,516 New +$64.1M
PTGX icon
5
Protagonist Therapeutics
PTGX
$3.67B
$43.3M 8.5% 2,449,183 – –
MGTX icon
6
MeiraGTx Holdings
MGTX
$587M
$36.3M 7.13% 2,898,550 – –
PRVB
7
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$15.9M 3.12% 1,124,973 – –
PHGE icon
8
BiomX
PHGE
$14.3M
$11.8M 2.31% 2,133,402 – –
PHAS
9
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$7.39M 1.45% 1,607,044 – –
ALDX icon
10
Aldeyra Therapeutics
ALDX
$351M
$2.48M 0.49% 594,834 – –
CSLT
11
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$673K 0.13% 811,295 – –
GYRE icon
12
Gyre Therapeutics
GYRE
$703M
$393K 0.08% 66,951 – –
GNCA
13
DELISTED
Genocea Biosciences, Inc.
GNCA
$331K 0.07% 143,964 – –
SENS icon
14
Senseonics Holdings
SENS
$374M
$205K 0.04% 525,632 – –
TCON
15
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$165K 0.03% 84,003 – –